Cocaine: history, social implications, and toxicity: a review

Seminars in Diagnostic Pathology

Volumn 26, Issue 1, 2009, Pages 10-17

  Goldstein, Rachel A ^a   DesLauriers, Carol ^b   Burda, Anthony ^b   Johnson Arbor, Kelly ^c  

^a NORTHWESTERN MEMORIAL HOSPITAL   (United States)

^b ILLINOIS POISON CENTER   (United States)

^c UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Cocaine; Metabolism; Structure; Uses

Indexed keywords

COCAINE; ILLICIT DRUG; QUININE; STRYCHNINE;

ARTICLE; CARDIOVASCULAR SYSTEM; CENTRAL NERVOUS SYSTEM; DRUG ABSORPTION; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG METABOLISM; EMERGENCY WARD; HEALTH CARE; HEART DISEASE; HEMODIALYSIS; HISTORY; HUMAN; KIDNEY FAILURE; LABORATORY TEST; LUNG DISEASE; NONHUMAN; PRIORITY JOURNAL; TOXICITY;

COCAINE; COCAINE-RELATED DISORDERS; DRUG INTERACTIONS; HISTORY, 15TH CENTURY; HISTORY, 19TH CENTURY; HISTORY, 20TH CENTURY; HUMANS; SOCIAL CHANGE; STREET DRUGS; VASOCONSTRICTOR AGENTS;

EID: 59249102765     PISSN: 07402570     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semdp.2008.12.001     Document Type: Article

References (46)

1. Altman A.J., Albert D.M., and Fournier G.A. Cocaine's use in ophthalmology: our 100 year heritage. Surv Ophthalmol 29 (1985) 300-307
2. Gay G.R., Inaba D.S., Sheperd C.W., and Newmyer J.A. Cocaine: history, epidemiology, human pharmacology and treatment. A perspective on a new debut for an old girl. Clin Toxicol 8 (1975) 149-178
3. Piek J., Lidke G., and Terberger T.H. Ancient trephinations in neolithic people: evidence for Stone Age neurosurgery?. Nature Precedings: hdl: 10101/npre. 2008.1615.1. Posted 21 Feb (2008)
4. Monardes N. Joyfull Newes out of the Newe Founde Worlde (1925), Alfred Knopf, New York, NY
5. May CD: How Coca-Cola obtains its coca. The New York Times, July 1, 1998. Accessed December 4, 2007
6. Benson D: Coca kick in drinks spurs export fears. The Washington Times, April 20, 2004. Accessed April 16, 2004. The legal importation of coca leaf. Accessed February 11, 2007
7. The Consumers Union Report on Licit and Illicit Drugs by Edward M. Brecher and the Editors of Consumer Reports Magazine, 1972. Public Law No. 223, 63rd Cong., approved December 17, 1914
8. Jatlow P. Cocaethylene: pharmacologic activity and clinical significance. Ther Drug Monit 15 (1993) 533-536
9. McCance E.F., Price L.H., Kosten T.R., et al. Cocaethylene: pharmacology, physiology and behavioral effects in humans. J Pharmacol Exp Ther 274 (1995) 215-223
10. Boghdadi M.S., and Henning R.J. Cocaine: pathophysiology and clinical toxicology. Heart Lung 26 (1997) 466-483
11. Shannon M. Clinical toxicity of cocaine adulterants. Ann Emerg Med 17 (1988) 1243-1247
12. McKinney C.D., Postiglione K.F., and Herold D.A. Benzocaine-adulterated street cocaine in association with methemoglobinemia. Clin Chem 38 (1992) 596-597
13. Prasad R.S., Kodali V.R., Kuraijam G.S., et al. Acute confusion and blindness from quinine toxicity. Eur J Emerg Med 10 (2003) 353-356
14. Wood D.M., Webster E., Martinez D., et al. Case report: survival after deliberate strychnine self-poisoning, with toxicokinetic data. Crit Care 6 (2002) 456-459
15. O'Callaghan W.G., Joyce N., and Counihan H.E. Unusual strychnine poisoning and its treatment: report of eight cases. Br Med J 285 (1982) 478
16. Ursitti F., Klein J., and Koren G. Confirmation of cocaine use during pregnancy: a critical review. Ther Drug Monit 23 (2001) 347-353
17. Warner E.A. Cocaine abuse. Ann Intern Med 119 (1993) 226-235
18. Burke W.M., Ravi N.V., Dhopesh V., et al. Prolonged presence of metabolite in urine after compulsive cocaine use. J Clin Psychiatry 51 (1990) 145-148
19. Weiss R.D., and Gawin F.H. Protracted elimination of cocaine metabolites in long-term, high-dose cocaine abusers. Am J Med 85 (1988) 879-880
20. Baselt R.C., and Baselt D.R. Little cross-reactivity of local anesthetics with Abuscreen. EMIT d.a.u., and TDX immunoassays for cocaine metabolite (letter). Clin Chem 33 (1987) 747
21. Mazor S.S., Mycyk M.B., Wills B.K., et al. Coca tea consumption causes positive urine cocaine assay. Eur J Emerg Med 13 (2006) 340-341
22. Mikkelsen S.L., and Ash K.O. Adulterants causing false negatives in illicit drug testing. Clin Chem 34 (1988) 2233-2236
23. Stephens B.G., Jentzen J.M., Karch S., et al. Criteria for the interpretation of cocaine levels in human biological samples and their relation to the cause of death. Am J Forensic Med Pathol 25 (2004) 1-10
24. Karch S.B. Introduction to the forensic pathology of cocaine. Am J Forensic Med Pathol 12 (1991) 126-131
25. Gruszecki A.C., Robinson C.A., Embry J.H., et al. Correlation of the incidence of cocaine and cocaethylene in hair and postmortem biologic samples. Am J Forensic Med Pathol 21 (2000) 166-171
26. Koren G., Klein J., Forman R., et al. Hair analysis of cocaine: differentiation between systemic exposure and external contamination. J Clin Pharmacol 32 (1992) 671-675
27. Roldan C.J. Toxicity, cocaine. http://www.emedicine.com/med/topic 400.htm Accessed June 1, 2008
28. Catterall W.A., and Mackie K. Local anesthetics. In: Brunton L.J., Parker K.L., Buxton I., et al. (Eds). Goodman and Gilman's The Pharmacological Basis of Therapeutics. (ed 11) (2006), McGraw Hill, New York, NY
29. Shanti C.M., and Lucas C.E. Cocaine and the critical care challenge. Crit Care Med 31 (2003) 1851-1859
30. Knuepfer M. Cardiovascular disorders associated with cocaine use: myths and truths. Pharmacol Ther 97 (2003) 181-222
31. Hoffman R.S. Cocaine. In: Flomenbaum N.E., Goldfrank L.R., Hoffman R.S., et al. (Eds). Goldfrank's Toxicologic Emergencies. (ed 8) (2006), McGraw Hill, New York, NY 1133-1146
32. Lason W. Neurochemical and pharmacological aspects of cocaine-induced seizures. Pol J Pharmacol 53 (2001) 57-60
33. O'Dell L., George F.R., and Ritz M.C. Antidepressant drugs appear to enhance cocaine-induced toxicity. Exp Clin Psychpharmacol 8 (2000) 133-141
34. Liu D., Hariman R.J., and Bauman J.L. Cocaine concentration-effect relationship in the presence and absence of lidocaine: evidence of competitive binding between cocaine and lidocaine. J Pharmacol Exp Ther 276 (1996) 568-577
35. McCord J., Hani J., and Hollander J.E. Management of cocaine-associated chest pain and myocardial infarction: a scientific statement from the American Heart Association acute cardiac care committee of the council on clinical cardiology. Circulation 117 (2008) 1897-1907
36. Tella S.R., Schindler C.W., and Goldberg S.R. Cocaine: cardiovascular effects in relation to inhibition of peripheral neuronal monoamine uptake and central stimulation of the sympathoadrenal system. J Pharmacol Exp Ther 267 (1993) 153-162
37. Jeffcoat A., Perez-Reyes M., Hill J., et al. Cocaine disposition in humans after intravenous injection, nasal insufflation (snorting), or smoking. Drug Metab Dispos 17 (1989) 153-159
38. Klasco RK (ed): Cocaine. POISINDEX® System. Greenwood Village, CO, Thomson Healthcare (edition expires 9/2008)
39. Leikin J., and Paloucek F. Cocaine. Poisoning and Toxicology Handbook. (ed 4) (2008), Informa Health Care: CRC Press 13
40. Baslet R. Cocaine. Disposition of Toxic Drugs and Chemicals in Man. (ed 6) (2002), Biomedical Publications, Foster City, CA 247-253
41. Hoffman R.S. Cocaine. In: Flomenbaum N.E., Goldfrank L.R., Hoffman R.S., et al. (Eds). Goldfrank's Toxicologic Emergencies. (ed 8) (2006), McGraw Hill, New York, NY 1133-1146
42. Maurer H., Sauer C., and Theobald D. Toxicokinetics of drugs of abuse: current knowledge of the isoenzymes involved in the human metabolism of tetrahydrocannabinol, cocaine, heroin, morphine, and codeine. Drug Monit 28 (2006) 447-453
43. Kolbrich E., Barnes A., Gorelick D., et al. Major and minor metabolites of cocaine in human plasma following controlled subcutaneous cocaine administration. J Anal Toxicol 30 (2006) 501-511
44. Huestis M., Darwin W., Shimomura E., et al. Cocaine and metabolites urinary excretion after controlled smoked administration. J Anal Toxicol 21 (2007) 462-468
45. Cone E., Tsadic A., Oyler H., and Darwin W. Cocaine metabolism and urinary excretion after different routes of administration. Proceedings of the Fifth International Congress of Therapeutic Drug Monitoring and Clinical Toxicology 20 (1998) 556-560
46. Jufer R., Walsh S., Cone E., and Smapson-Cone A. Effect of repeated cocaine administration on detection times in oral fluid and urine. J Anal Toxicol 30 (2006) 458-462